Magea13 attenuates myocardial injury in acute myocardial infarction by inhibiting the cAMP-PKA signaling pathway
Magea13 has been demonstrated to offer protection against AMI myocardial injury through the cAMP-PKA signaling pathway and is therefore a promising therapeutic and predictive target for AMI myocardial injury.
Authors
- Hualei Dai
- Yi Xiang
- Kanghui Ge
- Xiaoyu Xu (ORCID: https://orcid.org/0000-0002-0327-7369)
- Jialin Zheng (ORCID: https://orcid.org/0000-0003-2286-0151)
- Ziwei Zhang (ORCID: https://orcid.org/0000-0002-5705-4611)
Institutions
- Yunnan University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Kunming Medical University (CN)
- Second People's Hospital of Yunnan Province (CN)
Publication Details
- Journal
- APOPTOSIS
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1007/s10495-025-02078-0
- Citations
- 5
- Primary Topic
- Signaling Pathways in Disease
- Type
- article
- Field-Weighted Citation Impact
- 4.03